𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reinforcement Learning Strategies for Clinical Trials in Nonsmall Cell Lung Cancer

✍ Scribed by Yufan Zhao; Donglin Zeng; Mark A. Socinski; Michael R. Kosorok

Book ID
109224506
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
663 KB
Volume
67
Category
Article
ISSN
0006-341X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Implications of key trials in advanced n
Implications of key trials in advanced nonsmall cell lung cancer
✍ Philip D. Bonomi πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 163 KB πŸ‘ 1 views

## Abstract Many different targeted therapies with varying mechanisms of action have been added to standard first‐line chemotherapy doublets in an effort to improve survival of patients with advanced nonsmall cell lung cancer (NSCLC). Only 2 targeted therapiesβ€”bevacizumab and cetuximabβ€”have been as

Venous thromboembolism and nonsmall cell
Venous thromboembolism and nonsmall cell lung cancer : A pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials
✍ Lisa K. Hicks; Matthew C. Cheung; Keyue Ding; Baktiar Hasan; Lesley Seymour; Aur πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 174 KB πŸ‘ 2 views

## Abstract ## BACKGROUND: Advanced nonsmall cell lung cancer (NSCLC) is associated with venous thromboembolism (VTE). However, to the authors' knowledge, the incidence of VTE in early NSCLC, predictors of VTE, and the prognostic significance of VTE in NSCLC have not been explored. ## METHODS: I